Does intramuscular vitamin K1 act as an unintended depot preparation?

Journal of Paediatrics and Child Health

Volumn 32, Issue 3, 1996, Pages 251-254

  Loughnan, P M ^a   Mcdougall, P N ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

delayed action preparation; haemorrhagic disease; injection; intramuscular; menaquinone; vitamin K

Indexed keywords

FARNOQUINONE; PHYTOMENADIONE; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLEEDING DISORDER; BREAST MILK; DIET; DRUG ABSORPTION; DRUG EFFICACY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; DELAYED RELEASE FORMULATION; INFANT; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; REVIEW; TREATMENT OUTCOME;

ANTIFIBRINOLYTIC AGENTS; DELAYED-ACTION PREPARATIONS; HEMORRHAGIC DISEASE OF NEWBORN; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; TREATMENT OUTCOME; VITAMIN K 1;

EID: 0029662046     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb01564.x     Document Type: Article

References (46)

1. Greer FR. Factors influencing vitamin K status of the newborn. In Picciano MF, Lonnerdal B, eds. Mechanisms Regulating Lactation and Infant Nutrient Utilization. Wiley-Liss, New York, 1992; 259-71.
2. Shearer MJ. Vitamin K metabolism and nutriture. Blood Rev. 1992; 6: 92-104.
3. von Kries R, Shearer MJ, Gobel U. Vitamin K in infancy. Eur. J. Pediatr. 1988; 147: 106-12.
4. 1 content of maternal milk: Influence of the stage of lactation, lipid composition and vitamin KI supplements given to the mother. Pediatr. Res. 1987; 22: 513-17.
5. Greer FR, Marshall S, Cherry J, Suttie JW. Vitamin K status of lactating mothers, human milk and breastfeeding infants. Pediatrics 1991; 88: 751-6.
6. Usui Y, Tanimura H, Nishumura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am. J. Clin. Nutr. 1990; 51: 846-52.
7. Committee on Nutrition, US Academy of Pediatrics. Vitamin K compounds and the water soluble analogues: use in therapy and prophylaxis in pediatrics. Pediatrics 1961; 28: 501-6.
8. Shearer MJ. Absorption, metabolism and storage of K vitamins in the newborn. In Suzuki S, Hathaway W, Bonnar J, Sutor A, eds. Perinatal Thrombosis and Haemostasia. Springer-Verlag, Tokyo, 1991; 203-11.
9. Bentley R, Meganathan R. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol. Rev. 1982; 46: 241-80.
10. Duello TJ, Matschiner JT. Characterization of vitamin K from human liver. J. Nutr. 1972; 102: 341-6.
11. 2 in infant human liver. J. Pediatr. Gastroenterol. Nutr. 1989; 8: 304-7.
12. Matschiner JT, Taggart WV. Bioassay of vitamin K by intracardial injection in deficient adult male rats. J. Nutr. 1968; 94: 57-9.
13. Greer F, Suttie J. Vitamin K and the newborn. In Tsang R, Nichols B, eds. Nutrition During Infancy. CV Mosby Co., Philadelphia, 1988; 289-97.
14. 1 in man. In Suttie JW, ed. Vitamin K Metabolism and Vitamin K-dependent Proteins. University Park Press, Baltimore, 1980; 328-32.
15. McCarthy PT, Shearer MJ, Gau G, Crampton OE, Barkham P. Vitamin K content of human liver at different ages. Haemostasis 1986; 16 (Suppl.): 84-5.
16. Motahara K, Matsukura M, Matsuda I et al. Severe vitamin K deficiency in breast-fed infants. J. Pediatr. 1984; 105: 943-5.
17. Stark PL, Lee A. The microbial ecology of the large bowel of breast fed and formula fed infants during the first year of life. J. Med. Microbiol. 1982; 15: 189-203.
18. Ramotar K, Conly JM, Chubb H, Louie TJ, Production of menaquinones by intestinal anaerobes. J. Infect. Dis. 1984; 150: 213-18.
19. Kindberg C, Suttie JW, Uchida K, Hirauchi K, Nakao H. Menaquinone production and utilization in germ-free rats after inoculation with specific organisms. J. Nutr. 1987; 117: 1032-5.
20. 2 (menaquinone) in newborns during the first week of life. Pediatrics 1988; 81: 137-40.
21. Suttie JW, Mummah-Schendel LL, Shah DV, Lyle BJ, Greger JL Vitamin K deficiency from dietary vitamin K restriction in humans. Am. J. Clin. Nutr. 1988; 47: 475-8.
22. 1 in mothers and their newborn babies. Lancet 1982; ii: 460-3.
23. Loughnan P, McDougall P. The epidemiology of late onset haemorrhagic disease: A pooled data analysis. J. Paediatr. Child Health 1993; 29: 177-81.
24. 1 in neonates. Arch. Dis. Child. 1985; 60: 814-18.
25. von Kries R. Vitamin K in infancy (reply). Eur. J. Pediatr. 1988; 148: 177-8.
26. McNinch A, Tripp J. Haemorrhagic disease in the newborn in the British Isles: Two year prospective study. BMJ 1991; 303: 1105-9.
27. von Kries R. Vitamin K prophylaxis-a useful public health measure? Paediatr. Perinat. Epidemiol. 1992; 6: 7-15.
28. Hathaway WE. New insights on vitamin K. Hematol. Oncol. Clin. North Am. 1987; 1: 367-79.
29. Anonymous. Vitamin K and the newborn (Editorial). Lancet 1978; i: 755-7.
30. Tripp JH, McNinch AW. Haemorrhagic disease and vitamin K. Arch. Dis. Child. 1987; 62: 436-7.
31. Fetus and Newborn Committee, Canadian Paediatric Society. The use of vitamin K in the perinatal period. Can. Med. Assoc. J. 1988; 139: 127-30.
32. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992; 305: 341-6.
33. Klebanoff MA, Read JS, Mills JL, Shiono PH. The risk of childhood cancer after neonatal exposure to vitamin K. N. Engl. J. Med. 1993; 329: 905-8.
34. Ekelund H, Finnstrom O, Gunnarskog J, Kallen B, Larsson Y. Administration of vitamin K to newborn infants and childhood cancer. BMJ 1993; 307: 89-91.
35. Olsen JH, Hertz H, Blinkenberg K, Verder H. Vitamin K regimens and incidence of childhood cancer in Denmark. BMJ 1994; 308: 895-6.
36. Ekelund H. Late haemorrhagic disease in Sweden 1987-89. Acta Paediatr. Scand. 1991; 80: 966-8.
37. Tonz O, Schubiger G. Neonatale vitamin-K-prophylaxe und vitamin-K-mangelblutungen in der Schweiz 1986-1988. Schweiz. Med. Wochenschr. 1988; 118: 1747-52.
38. Mandell GL, Sande MA. Antimicrobial agents. In Gilman AG, Rail TW, Nies AS, Taylor P, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 8th edn. Permagon Press, Inc., New York, 1991; 1071.
39. Windholz M, ed. The Merck Index. Merck and Co., Inc., New Jersey, 1983; 1437-8.
40. 1, PIVKA II, and clotting factors in breast fed infants. Arch. Dis. Child. 1992; 67: 1250-4.
41. 1 concentrations in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed micelle preparation of phylloquinone. J. Pediatr. Gastroenterol. Nutr. 1993; 16: 435-9.
42. 1. J. Paediatr. Child Health 1996; 32: 187-8.
43. von Kries R, Gobel U. Oral vitamin K prophylaxis and later haemorrhagic disease of the newborn. Lancet 1994; 343: 352.
44. Loughnan P, Chant K, Elliott E, Henderson-Smart D, McDougall P. Haemorrhagic disease in Australia, 1993-94. Report from the Australian Paediatric Serveillance Unit (Abstract). J. Paediatr. Child Health 1995; 31:A2.
45. 1 to prevent vitamin K deficiency in breastfed infants. J. Pediatr. Gastroenterol. Nutr. 1993; 16: 301-5.
46. 1 (20) in children with cholestasis. J. Pediatr. Gastroenterol. Nutr. 1992; 14: 160-5.